Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States

Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma

(2015) Luciano J. Costa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century

(2015) Dianne Pulte et al.   BRITISH JOURNAL OF HAEMATOLOGY

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model

(2015) Hedwig M. Blommestein et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

(2015) Antonio Palumbo et al.   JOURNAL OF CLINICAL ONCOLOGY

Early mortality in multiple myeloma

(2015) L J Costa et al.   LEUKEMIA

Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era

(2014) L. Tao et al.   BLOOD

Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression–Related Death

(2014) Philippe Moreau et al.   JOURNAL OF CLINICAL ONCOLOGY

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

(2014) C J Heuck et al.   LEUKEMIA

Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma

(2013) Luciano J. Costa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

(2013) A. Baker et al.   BLOOD

Marital Status and Survival in Patients With Cancer

(2013) Ayal A. Aizer et al.   JOURNAL OF CLINICAL ONCOLOGY

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

(2013) S K Kumar et al.   LEUKEMIA

Recent improvement in survival of patients with multiple myeloma: variation by ethnicity

(2013) Dianne Pulte et al.   LEUKEMIA & LYMPHOMA

Health Care Costs and Resource Utilization, Including Patient Burden, Associated With Novel-Agent-Based Treatment Versus Other Therapies for Multiple Myeloma: Findings Using Real-World Claims Data

(2013) A. Teitelbaum et al.   ONCOLOGIST

Comparative Effectiveness Research in Oncology: An Overview

(2012) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

(2012) H Avet-Loiseau et al.   LEUKEMIA

Estimated Deaths Attributable to Social Factors in the United States

(2011) Sandro Galea et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival

(2011) Xianglin L. Du et al.   CANCER

Multiple myeloma and the road to personalised medicine

(2011) Stephen J Russell et al.   LANCET ONCOLOGY

Racial disparities in incidence and outcome in multiple myeloma: a population-based study

(2010) A. J. Waxman et al.   BLOOD

Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial

(2010) Jean-Luc Harousseau et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989

(2009) Michael Schaapveld et al.   EUROPEAN JOURNAL OF CANCER

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

(2009) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis

(2009) O Landgren et al.   LEUKEMIA

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE